These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9808853)

  • 1. Effects of vasoactive agents in healthy and diseased human saphenous veins.
    Rizzi A; Quaglio D; Vasquez G; Mascoli F; Amadesi S; Calò G; Regoli D; Zamboni P
    J Vasc Surg; 1998 Nov; 28(5):855-61. PubMed ID: 9808853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ mobilization in saphenous vein smooth muscle cells derived from patients with primary varicosity.
    Schuller-Petrovic S; Stessel H; Brunner F
    Eur J Clin Invest; 2002 Sep; 32(9):649-56. PubMed ID: 12486863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness of human varicose saphenous veins to vasoactive agents.
    Brunner F; Hoffmann C; Schuller-Petrovic S
    Br J Clin Pharmacol; 2001 Mar; 51(3):219-24. PubMed ID: 11298067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional adaptation of venous smooth muscle response to vasoconstriction in proximal, distal, and varix segments of varicose veins.
    Raffetto JD; Qiao X; Beauregard KG; Tanbe AF; Kumar A; Mam V; Khalil RA
    J Vasc Surg; 2010 Apr; 51(4):962-71. PubMed ID: 20347695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the differential sensitivity to norepinephrine and angiotensin II in the ovine uterine vasculature.
    Rosenfeld CR; DeSpain K; Liu XT
    Am J Physiol Regul Integr Comp Physiol; 2012 Jan; 302(1):R59-67. PubMed ID: 22031783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of salt intake and angiotensin II on vascular reactivity to endothelin-1.
    Ballew JR; Watts SW; Fink GD
    J Pharmacol Exp Ther; 2001 Feb; 296(2):345-50. PubMed ID: 11160616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelium and nitric oxide in the in vitro response of equine colonic venous rings to vasoconstrictor agents.
    Moore RM; Venugopalan CS; Sedrish SA; Holmes EP
    Am J Vet Res; 1997 Oct; 58(10):1145-51. PubMed ID: 9328669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human saphenous vein in pharmacology: effect of a new micronized flavonoidic fraction (Daflon 500 mg) on norepinephrine induced contraction.
    Juteau N; Bakri F; Pomies JP; Foulon C; Rigaudy P; Pillion G; Lange G; Genre O; Cron JP
    Int Angiol; 1995 Sep; 14(3 Suppl 1):8-13. PubMed ID: 8919257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins.
    Raffetto JD; Khalil RA
    J Vasc Surg; 2011 Aug; 54(2):489-96. PubMed ID: 21498026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prostaglandin synthesis does not affect contractile responses to noradrenaline, serotonin, angiotensin II nor endothelin-1 in human forearm isolated veins.
    Chin JP; Hurlston RM; Dart AM
    Br J Clin Pharmacol; 1993 Oct; 36(4):303-7. PubMed ID: 12959307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of endothelin receptors in human varicose veins.
    Barber DA; Wang X; Gloviczki P; Miller VM
    J Vasc Surg; 1997 Jul; 26(1):61-9. PubMed ID: 9240323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein.
    Cracowski JL; Stanke-Labesque F; Sessa C; Hunt M; Chavanon O; Devillier P; Bessard G
    Can J Physiol Pharmacol; 1999 Oct; 77(10):770-6. PubMed ID: 10588481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of stress and in vivo vasoactive intestinal peptide (VIP) treatment on the response of isolated rat aorta to norepinephrine, angiotensin II and vasopressin, and adventitial mast cells.
    Tunçel N; Erkasap N; Sahintürk V
    Stress; 2000 Nov; 3(4):299-308. PubMed ID: 11342395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.
    Camarda V; Rizzi A; Calò G; Gendron G; Perron SI; Kostenis E; Zamboni P; Mascoli F; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):141-9. PubMed ID: 11819032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein.
    Yagi S; Takata S; Kiyokawa H; Yamamoto M; Noto Y; Ikeda T; Hattori N
    Diabetes; 1988 Aug; 37(8):1064-7. PubMed ID: 3292327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human saphenous vein grafts explanted from the arterial circulation demonstrate altered smooth-muscle and endothelial responses.
    Park TC; Harker CT; Edwards JM; Moneta GL; Taylor LM; Porter JM
    J Vasc Surg; 1993 Jul; 18(1):61-8; discussion 68-9. PubMed ID: 8326660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
    Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
    J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine responses in rat renal and femoral veins are reinforced by vasoconstrictor prostanoids.
    de Souza Rossignoli P; Yamamoto FZ; Pereira OC; Chies AB
    Vascul Pharmacol; 2015 Sep; 72():93-100. PubMed ID: 26141930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.